Market Access News | pharmaphorum

News

BeOne gets the nod for BCL2 inhibitor Beqalzi in mantle cell lymphoma, while Taiho's Inqovi has acute myeloid leukaemia added to its label.

News

LSE pharma policy expert contends the MHRA/NICE aligned pathway is weighted towards industry, and calls for an assessment of its impact on the NHS.

News

According to multiple press reports citing anonymous insider sources, Dr Marty Makary has resigned after a year at the head of the FDA.

News

Lawmakers in the EU have reached a provisional agreement to strengthen the bloc's critical medicine supply chain and avert the risk of shortages.

News

After nearly two years of wrangling, ITF's Duvyzat can be used by the NHS to treat people living with Duchenne muscular dystrophy.

News

Partner's Bizengri has been approved for a rare form of bile duct cancer, two days after being awarded a national priority review voucher.